May
24
2024

MAGIC-01: A study of a new vaccine against Marburg virus in adults aged 18 – 55 years

By OVG

You are invited to take part in a study to investigate a new vaccine against Marburg virus. The study is being led by the Oxford Vaccine Group, which is part of the University of Oxford. The study will take place at the Oxford Vaccine Group, Centre for Clinical Vaccinology & Tropical Medicine (CCVTM).

Sep
14
2023

The 6-in-1 Part 2 Vaccine Study

By OVG

 

The 6-in-1 Part 2 Vaccine Study

 

Recruiting now for The 6-in-1 Part 2 Vaccine Study. Oxford Vaccine Group, University of Oxford would like to invite your child to take part in a study to help guide future changes to the UK immunisation schedule. We want to enroll healthy children, who have not yet received their 12-month routine vaccinations.

Aug
18
2023

BIO-001

By OVG

 

We are looking for healthy volunteers to take part in a study to find a vaccine against Malaria.

Jul
09
2018

POInT

By OVG

The Oxford Vaccine Group is recruiting infants aged 4 – 7 months to a type 1 diabetes prevention trial. POInT (Primary Oral Insulin Trial) is recruiting infants who were screened for diabetes at birth through the INGR1D Study and have been found to be at high risk for developing diabetes.

Centre for Clinical Vaccinology and Tropical Medicine, Churchill Hospital, University of Oxford, OX3 7LE.

This unit receives National Institute for Health Research CTU Support Funding. This funding has been awarded to support the unit in developing and supporting NIHR trials.